Please login or sign up to post and edit reviews.
FDA Advisers Back Novavax Vaccine for Authorization
Publisher |
iHeartPodcasts
Media Type |
audio
Categories Via RSS |
Health & Fitness
Publication Date |
Jun 08, 2022
Episode Duration |
00:06:28

Vaccine experts advising the FDA have endorsed a new Covid vaccine made by Novavax saying that the shot’s benefits outweigh any risks associated with it.  The vaccine will still need full approval before coming on the market, but it will be the first one available using a more traditional, protein-based technology.  Liz Essley Whyte, reporter at the WSJ, joins us for what to know about its effectiveness and concerns.

See omnystudio.com/listener for privacy information.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review